|
|
|
|
|
13.01.26 - 08:15
|
Research: Daiwa Raises WUXI BIO TP to $42, Keeps Buy Rating (AAStocks)
|
|
|
Daiwa released a research report raising its target price for WUXI BIO (02269.HK) from $35.5 to $42, with rating kept at Buy. The broker lifted its 2025-2027 EPS forecasts for WUXI BIO by 1-5%, based on higher project signing expectations and continued operational leverage, and raised its 2028-2032 revenue forecasts by 3-7%, bas......
|
|
|
|
|
|
|
13.01.26 - 06:12
|
China′s SciNeuro, Novartis sign US$1.7 billion licensing deal to develop Alzheimer′s drugs (SCMP)
|
|
|
A partnership between China's SciNeuro Pharmaceuticals and Swiss pharmaceutical giant Novartis on Monday has revived hopes for treating Alzheimer's disease.
The deal, worth nearly US$1.7 billion, grants Novartis exclusive worldwide rights to develop and commercialise SciNeuro's antibody candidates to develop drugs for the progressive brain disease.
SciNeuro's novel amyloid beta targeted antibody programme leverages proprietary blood-brain barrier shuttle technology to help more of the drug cross......
|
|
|
13.01.26 - 05:45
|
Research: CMBI Ratings, TPs on Pharma (Table) (AAStocks)
|
|
|
Shares | Ratings | Target prices (HK$)3SBIO(01530.HK) | Buy | 37.58 GUSHENGTANG(02273.HK) | Buy | 44.95 SINO BIOPHARM(01177.HK) | Buy | 9.4 WUXI XDC(02268.HK) | Buy | 74 ~AAStocks Financial NewsWeb Site: www.aastocks.com...
|
|
|
|
|
|
|
|
|
|
|
13.01.26 - 05:00
|
Research: M Stanley's Latest HK Stock Focus List (Table) (AAStocks)
|
|
|
Stock | Potential Upside to Target PriceAlibaba (BABA.US) | 16.5%YANGTZE POWER (600900.SH) | 27.6%CONTEMPORARY AMPEREX (300750.SZ) | 32.7%DUALITYBIO-B (09606.HK) | 39.3%ESPRESSIF (688018.SH) | 26.9%HKEX (00388.HK) | 19.5%HKT-SS (06823.HK) | 10.7%NARI (600406.SH) | 12.3%PING AN (02318.HK) | 26.8%INOVANCE TECH (300124.SZ) | 22.5%S......
|
|
|
|
|
|
|
|
|
|
|
|
|
13.01.26 - 03:15
|
WUXI APPTEC Leaps 6%+ on Expectations of ~103% YoY Surge in 2025 NP (AAStocks)
|
|
|
WUXI APPTEC (02359.HK)'s stock price thrived this morning and once peaked at HKD117.8. It last stood at HKD117.8, up 6.32%, with a volume of 1.8442 million shares, involving HKD214 million.The company has issued a positive profit alert estimating its 2025 revenue to grow by 15.84% YoY to around RMB45.456 billion and its net ......
|
|
|
13.01.26 - 03:15
|
REMEGEN Once Spikes 14%+ After Granting AbbVie Exclusive License for RC148 (AAStocks)
|
|
|
REMEGEN (09995.HK) opened 8.8% higher at $101 today (13th), and once spiked 14.9% to a high of $106.6 in the morning session. It last printed at $101.2, rallying 9.05%, with a trading volume of 7.2058 million shares, involving $740 million.REMEGEN entered into an exclusive licensing agreement with AbbVie, under which AbbVie will......
|
|
|
13.01.26 - 03:00
|
H Shrs: HSI Opens 350 Pts Higher; BABA-W Soars 5%; WUXI APPTEC Surges 4.7% (AAStocks)
|
|
|
The NASDAQ Golden Dragon China Index rallied over 4%, among which Alibaba ADR (BABA.US) rocketed 10%, leading to a higher opening for Hong Kong stocks in the morning session. The HSI opened 350 points higher, or 1.3%, at 26,958; the HSCEI opened 115 points higher, or 1.2%, at 9,335; and the HSTECH opened 113 points higher, or 1.......
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
